Vasobral 30 pills

To favorites
Vasobral pills the drug reduces the permeability of the vascular wall, improves blood circulation and metabolic processes in the brain, increases the resistance of brain tissue to hypoxia
Pharmacological group:Brain health
Pills in 1 package:30
Country of origin:Italy
In stock
We deliver goods to almost any country. Each parcel is assigned a track number
You can pay by Paypal or any card Visa or Mastercard
Discount system
Cumulative discounts and Bonus program for our clients
Original goods
We offer our customers only original products

Instructions for Vasobral 30 pills

English product name
Vasodilating agent

Release form
tab 4 mg+40 mg: 10, 30, 60 or 90 pcs
Vasodilating agent


The tablets are almost white in color, round, flat, with a beveled edge, with a risk on one side and a stamp "VASOBRAL" on the other side.

Vasodilating agent
1 tab.
α-dihydroergocriptine mesylate 4 mg
caffeine 20 mg

Auxiliary substances:
lactose monohydrate - 94.1 mg,
cellulose microcrystalline (Avicel PH102) - 60 mg,
magnesium stearate - 1.5 mg,
silicon dioxide colloidal anhydrous (Aerosil 200) - 0.4 mg.

Vasodilating agent
10 pcs - blister packs (3) - cardboard packs.
10 pcs - blister packs (6) - cardboard packs.
Vasodilating agent

ATC codes
Vasodilating agent

Clinical-pharmacological groups / Group affiliation
A drug Vasobral that improves cerebral circulation
Vasodilating agent
Active substance
alpha-dihydroergocriptine mesylate
Vasodilating agent

Pharmacotherapy group
Vasodilating agent
The shelf life is four years.

Testimony Vasobral:

cerebrovascular insufficiency (including cerebral atherosclerosis);
Consequences of cerebral circulation disorders;
vestibular and labyrinthine disorders
dizziness, tinnitus, hypoacusia, ischaemic genesis
Meunier's disease.

Method of use, course and dosage Vasobral:

Used inwards, during meals, with a small amount of liquid, 1/2-one tablet. twice/day.
The duration of treatment is two to three months, and if necessary, treatment can be given once or twice a year

Nosology (ICD codes)
Ménière's disease
Benign paroxysmal dizziness
Other peripheral dizziness
Vestibular function violations unspecified
Labyrinthine dysfunction
Degenerative and vascular ear disease
Tinnitus (subjective)
Cerebral atherosclerosis
Effects of cerebrovascular disease
Dizziness and disturbance of stability

Pharmacological effect:

Combination drug Vasobral. α-dihydroergocriptin is a dihydrated derivative of the sporine, inhibiting α1 and α2 adrenergic receptors. It has dopaminergic, serotoninergic action, reduces aggregation of platelets and erythrocytes, reduces vascular wall permeability, increases the number of functioning capillaries, improves blood circulation and metabolic processes in the brain, increases resistance of brain tissues to hypoxia.

Caffeine has a psychostimulating and analeptic effect, enhances excitation processes in the cerebral cortex - increases mental and physical performance, reduces fatigue and drowsiness, increases reflexive excitability of the spinal cord, excites the respiratory and vascular centers, has diuretic effect.

Pharmacological group
Pills in 1 package
Country of origin
Expiration Date (in months)
No reviews yet — your comment may be first.
All reviews 0
general rating